Literature DB >> 14572447

Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies.

Pankajavalli Ramakrishnan1, Dennis W Dickson, Peter Davies.   

Abstract

Pin1, a peptidyl-prolyl isomerase binds to mitotic serine or threonine phosphoproteins. In Alzheimer's disease (AD) evidence points to the reactivation of mitosis in vulnerable neurons. Tangles composed of hyperphosphorylated tau contain phosphorylated Thr231 (pThr231 tau), which occurs to a greater extent in the AD brain than in the normal brain, and Pin1 has been shown to bind pThr231 tau. Here, Pin1 distribution in AD, and its colocalization with pThr231 tau in AD, FTDP-17 (P301L), Pick's disease (PiD), and PSP was investigated using TG-3, a monoclonal antibody to conformationally altered pThr231 tau. The Pin1 antibody A-20 detected granular Pin1 staining in AD brains, but not in normal brains. A-20 immunoreactive granules colocalized with TG-3-stained granules but not with TG-3-stained pretangles, tangles, or Pick bodies in AD, PiD, and FTDP-17 (P301L). Pin1 granules were sparse in PSP, and rarely did A-20 colocalize with TG-3. The appearance of Pin1 granules in the early stages of AD, PiD, and FTDP-17 (P301L) implicates Pin1 in their pathogenesis but not in PSP.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14572447     DOI: 10.1016/s0969-9961(03)00109-8

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  18 in total

1.  Post-phosphorylation prolyl isomerisation of gephyrin represents a mechanism to modulate glycine receptors function.

Authors:  M Moretto Zita; Ivan Marchionni; Elisa Bottos; Massimo Righi; Giannino Del Sal; Enrico Cherubini; Paola Zacchi
Journal:  EMBO J       Date:  2007-03-08       Impact factor: 11.598

Review 2.  Redox proteomics and amyloid β-peptide: insights into Alzheimer disease.

Authors:  D Allan Butterfield; Debra Boyd-Kimball
Journal:  J Neurochem       Date:  2018-11-27       Impact factor: 5.372

3.  Tau and GSK3beta dephosphorylations are required for regulating Pin1 phosphorylation.

Authors:  Sae H Min; Jung S Cho; Jae H Oh; Sun B Shim; Dae Y Hwang; Su H Lee; Seung W Jee; Hwa J Lim; Min Y Kim; Yhun Y Sheen; Seok H Lee; Yong K Kim
Journal:  Neurochem Res       Date:  2005-08       Impact factor: 3.996

Review 4.  Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.

Authors:  D Allan Butterfield; Marzia Perluigi; Tanea Reed; Tasneem Muharib; Christopher P Hughes; Renã A S Robinson; Rukhsana Sultana
Journal:  Antioxid Redox Signal       Date:  2012-01-18       Impact factor: 8.401

Review 5.  Topographic regulation of neuronal intermediate filaments by phosphorylation, role of peptidyl-prolyl isomerase 1: significance in neurodegeneration.

Authors:  B K Binukumar; Varsha Shukla; Niranjana D Amin; Preethi Reddy; Suzanne Skuntz; Philip Grant; Harish C Pant
Journal:  Histochem Cell Biol       Date:  2013-06-23       Impact factor: 4.304

6.  Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative disease.

Authors:  W Michael Caudle; Sheng Pan; Min Shi; Thomas Quinn; Jake Hoekstra; Richard P Beyer; Thomas J Montine; Jing Zhang
Journal:  Proteomics Clin Appl       Date:  2008-09-10       Impact factor: 3.494

7.  Granular expression of prolyl-peptidyl isomerase PIN1 is a constant and specific feature of Alzheimer's disease pathology and is independent of tau, Aβ and TDP-43 pathology.

Authors:  Ayoub Dakson; Osamu Yokota; Margaret Esiri; Eileen H Bigio; Michael Horan; Neil Pendleton; Anna Richardson; David Neary; Julie S Snowden; Andrew Robinson; Yvonne S Davidson; David M A Mann
Journal:  Acta Neuropathol       Date:  2011-01-18       Impact factor: 17.088

Review 8.  Pin1 in Alzheimer's disease: multiple substrates, one regulatory mechanism?

Authors:  Martin Balastik; Jormay Lim; Lucia Pastorino; Kun Ping Lu
Journal:  Biochim Biophys Acta       Date:  2007-01-23

9.  Pin1 cysteine-113 oxidation inhibits its catalytic activity and cellular function in Alzheimer's disease.

Authors:  Chun-Hau Chen; Wenzong Li; Rukhsana Sultana; Mi-Hyeon You; Asami Kondo; Koorosh Shahpasand; Byeong Mo Kim; Man-Li Luo; Morris Nechama; Yu-Min Lin; Yandan Yao; Tae Ho Lee; Xiao Zhen Zhou; Aaron M Swomley; D Allan Butterfield; Yan Zhang; Kun Ping Lu
Journal:  Neurobiol Dis       Date:  2015-01-06       Impact factor: 5.996

Review 10.  Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.

Authors:  Rukhsana Sultana; Marzia Perluigi; D Allan Butterfield
Journal:  Acta Neuropathol       Date:  2009-03-14       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.